Is intermediate radiation dose escalation with concurrent chemotherapy for stage III non-small-cell lung cancer beneficial? A multi-institutional propensity score matched analysis

  1. Rodrigues, G.
  2. Oberije, C.
  3. Senan, S.
  4. Tsujino, K.
  5. Wiersma, T.
  6. Moreno-Jimenez, M.
  7. Kim, T.H.
  8. Marks, L.B.
  9. Rengan, R.
  10. De Petris, L.
  11. Ramella, S.
  12. DeRuyck, K.
  13. Rodriguez De Dios, N.
  14. Warner, A.
  15. Bradley, J.D.
  16. Palma, D.A.
Journal:
International Journal of Radiation Oncology Biology Physics

ISSN: 1879-355X 0360-3016

Year of publication: 2015

Volume: 91

Issue: 1

Pages: 133-139

Type: Article

DOI: 10.1016/J.IJROBP.2014.09.033 GOOGLE SCHOLAR

Sustainable development goals